The Japanese gut microbiome: ecology, uniqueness, and impact on health and disease
Proceedings of the Japan Academy, Series B · 2026
DOI: 10.2183/pjab.102.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Proceedings of the Japan Academy, Series B, 2026. Verfasst von Suguru Nishijima und 2 weiteren Autor:innen. Beteiligte Einrichtung: Life Science Data Research Center, The University of Tokyo. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Health, Disease. Die Arbeit nennt 184 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Agency for Medical Research and Development, Japan Dairy Association, Takeda Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Life Science Data Research Center, The University of Tokyo.
- Faculty of Science and Engineering, Waseda University.
- Center for Health Surveillance and Preventive Medicine, Tokyo Medical University.
Förderung
- Japan Agency for Medical Research and Development
- Japan Dairy Association
- Takeda Science Foundation
- Tokyo Medical University
- COCKPI-T Funding
- National Center for Global Health and Medicine
- Japan Society for the Promotion of Science
- Smoking Research Foundation
Zitieren
APA
Nishijima, S., Hattori, M., & Nagata, N. (2026). The Japanese gut microbiome: ecology, uniqueness, and impact on health and disease. Proceedings of the Japan Academy, Series B. https://doi.org/10.2183/pjab.102.006
Vancouver
Nishijima S, Hattori M, Nagata N. The Japanese gut microbiome: ecology, uniqueness, and impact on health and disease. Proceedings of the Japan Academy, Series B. 2026. doi:10.2183/pjab.102.006
BibTeX
@article{Nishijima2026,
author = {Nishijima, Suguru and Hattori, Masahira and Nagata, Naoyoshi},
title = {The Japanese gut microbiome: ecology, uniqueness, and impact on health and disease},
journal = {Proceedings of the Japan Academy, Series B},
year = {2026},
doi = {10.2183/pjab.102.006}
}
EUVIMED